Clinical trial Recruiting at 1 site Interventional Ages 18 to 85

MINT Conditioning to Improve Gait

Official title: MINT Conditioning to Improve Post-stroke Gait

Run by Northwestern University · NCT07041775 · Data updated 2026-11-12

A myoelectric interface training is being tested to see if it can help adults with leg weakness from stroke walk better.

Quick facts

Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment72 (estimated)
SponsorNorthwestern University
Academic / other
Locations2 sites (Chicago, Illinois and 1 other locations)
StatusRecruiting
StartedJune 4, 2026
Main results expectedJanuary 2030
Study endsMarch 2030
Registry record updatedJune 8, 2026
Trial IDNCT07041775 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–85 with unilateral stroke and at least six months since onset, exhibiting severe to moderate gait impairment and gait asymmetry, who can stand unaided and follow task instructions.

Probably not a fit

Individuals with significant cognitive or visual impairments or other conditions that prevent engagement with the interactive training may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study tests a myoelectric interface for neurorehabilitation (MINT) conditioning to improve walking in adults who have stroke-related leg impairment for at least six months. Participants perform a game-like training that provides real-time muscle feedback to help retrain leg movement and reduce gait asymmetry. The approach uses one muscle myoelectric feedback during conditioning sessions and is conducted at Northwestern University and University of Texas Southwestern Medical Center. Enrollment targets adults with moderate to severe gait impairment and requires the ability to stand independently and follow task instructions. Exclusion criteria include cognitive or visual impairments that would interfere with task performance, as well as recent participation in other leg-focused studies or pharmacological trials.

Why it matters

Potential benefit: If successful, participants may experience improved walking speed and symmetry, leading to better mobility in daily life.

How similar studies have gone: Previous similar myoelectric or neurorehabilitation approaches have shown promise in improving gait, but results can vary by individual and protocol.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age at enrollment is 18 to 85
* Leg impairment from unilateral stroke at least 6 months prior to screening
* Severe to moderate gait impairment (ambulatory with a maximum walking speed of 0.8 m/s, i.e., half of normal speed)
* Able to stand without assistance
* Clinically observable gait asymmetry
* Abnormal co-activation between adductor magnus and rectus femoris (R greater than or equal to 0.5)

Exclusion Criteria:

* Cognitive impairment with at least moderately impaired attention on digit-span test, or unable to follow instructions of the MINT task
* Visual impairment (such as hemianopia) preventing sufficient perception of the screen to play the games
* Anesthesia or severe neglect in the affected leg, or visual hemineglect (score of 2 on the NIH Stroke Scale Extinction and Inattention subtest) that impairs ability to play the games
* Participation in another study on the affected leg, or any pharmacological study, within 6 weeks of enrollment
* Inability to understand or follow commands in English due to aphasia or other reason that makes it impossible to perform the training
* Diffuse or multifocal infarcts
* Substantial leg or other pain preventing participation for 60 minutes a day
* Spasticity treatment (pharmacological or Botox) on the affected leg within past 3 months
* Severe osteoporosis causing hip or other fractures
* History of multiple falls within the last year, use of walker for balance, or falling during stance while in the lab in the first session.
* Contracture limiting the range of motion of the leg
* Current pregnancy
* From the TMS portion of the study only: History of epilepsy in adulthood requiring antiseizure medications; recent/current alcoholism or benzodiazepine/barbiturate abuse or recent history of alcohol/benzodiazepine/barbiturate withdrawal, recent history of cocaine or amphetamine use, skull fractures or skull deficits, concussion within the last 6 months, unexplained recurring headaches, vagus nerve stimulator, cochlear implant, deep brain stimulator, intracranial/carotid stents, cardiac pacemaker/AICD.

Where it's running

  • Northwestern University
    Chicago, Illinois, United States
    Recruiting
  • University of Texas Southwestern Medical Center
    Dallas, Texas, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.